📄 Recross-examination of Roger Martz — Wednesday, July 26, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUL\26\RECROSS-EXAMINATION-OF-ROGER-M.DOC
TRIAL
▲ Day 122 of 167

Recross-examination of Roger Martz

Witness: Roger Martz
Examiner: Marcia Clark
Called by: Defense • Date: Wednesday, July 26, 1995 • Utterances: 223
Marcia Clark rehabilitates Agent Martz's EDTA testing methodology on recross, eliciting clear testimony that his oversampling technique actually favored the defense by over-representing any EDTA signal that might be present. Clark systematically dismantles a Defense chart (1271-C) by getting Martz to confirm it bears no relationship to any test he actually conducted, and concludes with unequivocal testimony that neither the gate blood nor the sock blood showed any EDTA from preserved blood. A sidebar erupts over Clark's questions implying the Defense had a burden to conduct its own tests, and Blasier separately accuses Martz of being deceptive about a pre-testimony conversation.
1 THE COURT:

Miss Clark.

RECROSS-EXAMINATION BY MS. CLARK

2 MS. CLARK:

Mr. Martz, why would it not be relevant to use more blood to determine whether or not you had EDTA from preserved blood?

3 MR. MARTZ:

As I mentioned earlier, it was--it was actually a very easy analysis. It may seem complicated, but it was actually very easy. The stains were taken from approximately the same amount. I always made sure that I took more stain from the questioned sample than I did the known, and as you saw from my charts, it is very easy to differentiate between blood that is preserved with EDTA and blood that is not preserved.

4 MS. CLARK:

And by taking more stain from the evidence, you would encourage higher readings from the evidence than you would ordinarily if you just took even amounts from the evidence and the reference sample?

5 MR. MARTZ:

That's correct.

6 MS. CLARK:

And in that way you overcompensate for any variation in size by making sure that the evidence reading is going to be over-represented?

7 MR. MARTZ:

That was my theory and that is why I did that, yes.

8 MS. CLARK:

So if anything, the readings that you got in the evidence graphs and chart results that you have overrepresent the amount of EDTA?

9 MR. MARTZ:

That's correct.

10 MS. CLARK:

Now, you talked about detection limits, sir.

11 (Brief pause.)
12 MS. CLARK:

We lost our operator, your Honor.

13 THE COURT:

Well, try it the old-fashioned way.

14 MS. CLARK:

What is that? I forgot.

15 MR. DARDEN:

May I use the phone, your Honor?

16 THE COURT:

You may. Proceed.

17 MS. CLARK:

Thank you, your Honor. I will go to something else for the moment.

18 MS. CLARK:

Sir, you talked about detection limit. Let me ask you this: Whatever size of bloodstain you take, be it five microliters, ten microliters, whatever, assume it is five microliters, that is very small isn't it?

19 MR. MARTZ:

Right.

20 MS. CLARK:

When you test five microliters of blood, if it is five microliters of blood that comes from a tube containing EDTA-preserved blood, will you detect EDTA?

21 MR. MARTZ:

Yes. It is veer easy to detect. In a stain with a positive ion mode it would even be one/tenth the size of a one-millimeter square, so it would be extremely small size.

22 MS. CLARK:

And if you run that same sample size, as small as it can be and it is unpreserved blood, will you detect EDTA?

23 MR. MARTZ:

In unpreserved blood?

24 MS. CLARK:

Right.

25 MR. MARTZ:

I have not been able to identify EDTA from bloodstains that size.

26 MS. CLARK:

Then what does that tell you about the detectable limit? If your signal is so weak, sir, that it is below the detectable limit in your bloodstain, does that tell you that EDTA has not been identified?

27 MR. MARTZ:

That's correct.

28 MS. CLARK:

In that respect, sir, is it irrelevant whether or not you use more blood or less blood?

29 MR. MARTZ:

As long as I use the same size stains, it is irrelevant.

30 MS. CLARK:

Because even if you use very little blood, EDTA will produce a strong signal if it is present?

31 MR. MARTZ:

That's correct.

32 MS. CLARK:

And by that I mean EDTA-preserved blood?

33 MR. MARTZ:

Yes.

34 MS. CLARK:

Now, Mr. Blasier asked you whether or not you ever called Defense attorneys to advise them of what you tell a Prosecutor about when you work on cases for prosecutorial agencies. Do you recall that?

35 MR. MARTZ:

Yes.

36 MS. CLARK:

Have you ever refused to speak to a Defense attorney who had questions of you?

37 MR. MARTZ:

No, no.

38 MS. CLARK:

Have you ever refused to speak to Mr. Blasier when he had questions of you, sir?

39 MR. MARTZ:

No.

40 MS. CLARK:

And has he had questions of you, sir, throughout these proceedings?

41 MR. MARTZ:

Yes, he has.

42 MS. CLARK:

And have you answered them?

43 MR. MARTZ:

Yes, I have.

44 MS. CLARK:

In fact, have you approached him to ask him if he had any questions?

45 MR. MARTZ:

Yes.

46 MS. CLARK:

And did he have some?

47 MR. MARTZ:

On several occasions, yes.

48 MS. CLARK:

Did you answer them?

49 MR. MARTZ:

Yes.

50 MS. CLARK:

You indicated, sir, that you were confused by the fact that he wanted to call you as a witness?

51 MR. MARTZ:

Yes.

52 MS. CLARK:

Why is that?

53 MR. MARTZ:

Because my--

54 MR. BLASIER:

Objection, argumentative.

55 THE COURT:

Overruled.

56 MR. MARTZ:

My results clearly show that EDTA is not present in the bloodstains in question.

57 MS. CLARK:

Now, sir, as to all of the evidence testing now, with that in mind, I mean the evidence of the blood on the gate, the blood on the sock, did you write reports containing your conclusions and your results and the testing procedures you followed to be provided to the Prosecution and the Defense?

58 MR. MARTZ:

Yes.

59 MS. CLARK:

And when did you provide those reports?

60 MR. MARTZ:

It was probably the end of February, the beginning of March. I don't have the exact date.

61 MS. CLARK:

Okay. And those reports indicated your conclusion that no EDTA from preserved blood was present in the evidence?

62 MR. MARTZ:

That's correct.

63 MS. CLARK:

And having provided them by the end of March, sir, if you wanted to prove that EDTA blood--preserved blood was present on the evidence stains, what tests would you conduct?

64 MR. MARTZ:

Well, I would conduct the tests that I performed here.

65 MS. CLARK:

To your knowledge has the Defense conducted such tests?

66 MR. MARTZ:

I have no knowledge of them conducting those tests, no.

67 MS. CLARK:

If you wanted to prove that EDTA-preserved blood, when you have EDTA-preserved blood that the EDTA will break down or degrade when subjected to sunlight, high intensity light, rust, fertilizer or metal or environmental conditions, would you conduct experiments under those conditions to prove that hypothesis?

68 MR. MARTZ:

Yes.

69 MS. CLARK:

To your knowledge has that ever been done by any Defense expert?

70 MR. MARTZ:

Not to my knowledge.

71 MS. CLARK:

In your opinion, sir, between the beginning of March, when you turned over your results and now, would there have been ample time to conduct those experiments?

72 MR. MARTZ:

I believe there would be, yes.

73 MS. CLARK:

Would there have been ample time, sir, to conduct any tests on the evidence?

74 MR. BLASIER:

Objection, your Honor. May we approach?

75 THE COURT:

Yes. With the court reporter, please.

76 (The following proceedings were held at the bench:)
77 THE COURT:

We are over at the side bar. Mr. Blasier.

78 MR. BLASIER:

The questions that are being asked are an attempt to shift the burden of proof to show that we have some kind of burden of doing testing, of going forward with testing, when we don't. And these are in the form of argument and comments on our--whether we are doing tests or not, and they are improper.

79 THE COURT:

I'm going to direct the Prosecution to rephrase regarding opportunity and time to do testing. That is what you can ask, whether or not somebody wanted to do this, there was ample opportunity.

80 MS. CLARK:

Okay.

81 THE COURT:

And time, not that the Defense had any obligation to do it, so stay away from the Defense. Having the opportunity, just any scientist interested in this.

82 MR. COCHRAN:

May I say something?

83 THE COURT:

Neutral question.

84 MR. COCHRAN:

In view of that, shouldn't we strike what they have already asked? They asked a series of questions along this line to straighten the record out because we don't have an obligation, Judge.

85 MS. CLARK:

I--

86 MR. COCHRAN:

Finish, please? Shouldn't we straighten that out, your Honor?

87 THE COURT:

Well, there is only one person who gets to argue these things, Mr. Cochran.

88 MS. CLARK:

The People's position is that the Defense has proffered this evidence, not the People, and we did not proffer this witness. He is subpoenaed by the Defense and was Dr. Rieders. All privilege has been waived now with respect to any testing they may or may not have done by having called a witness, and actually two witnesses on this issue, so I think it is fair comment.

89 THE COURT:

You are right, it is fair comment in argument that they had the opportunity to do this, they had the resources, they had the people to do it; they didn't do it. That is argument. And I'm going to direct you to rephrase your question in a neutral fashion that any scientist with the appropriate equipment, you know, since the time you completed your test, had the opportunity to do these other tests.

90 MS. CLARK:

Uh-huh.

91 THE COURT:

In time, equipment, skill, whatever, they could have done this, anybody could have done this, correct?

92 MS. CLARK:

Yes.

93 THE COURT:

In a neutral fashion. That is a fair question.

94 MR. BLASIER:

Your Honor, while we are here, I would like to be heard on this. Agent Martz told me right after lunch there is ten microliters in each one of these drops. I think he is becoming deceptive by denying that, and I want to state as an officer of the court that is what he told me. Ordinarily the proper way to impeach him would be to call myself as a witness to say that that is what he said. Obviously that presents additional problems. I'm not sure how to deal with that, but I--

95 THE COURT:

Let's not take it up now, because I have a feeling we are not going to finish with Martz this morning--this afternoon because we are--although you are about to finish in about two or three minutes--

96 MS. CLARK:

Yeah, exactly. I'm almost done.

97 THE COURT:

How about you?

98 MR. BLASIER:

I don't have much more.

99 THE COURT:

Well, we may slop over.

100 MS. CLARK:

Can we try and finish?

101 THE COURT:

We do have to end at 5:00 today.

102 MR. BLASIER:

If we can.

103 MS. CLARK:

I think we can.

104 THE COURT:

Counsel, the thing is, Bob wants to go into this.

105 MR. COCHRAN:

Yeah. Off the record.

106 MS. CLARK:

I wasn't present for the conversation, but the witness doesn't remember how much he actually used and Blasier asked off-the-cuff informally in Court--

107 THE COURT:

What we will do--

108 MS. CLARK:

He didn't know it was important.

109 THE COURT:

What we will do, the point I was making about the fact that we are probably not going to finish with this guy today is when we take the recess, let the jurors go, because their family visitation is this afternoon, which is why we have to quit at 5:00, we can chat with Agent Martz, so let's not take up the time and talk about it now. All right.

110 (The following proceedings were held in open court:)
111 THE COURT:

Thank you, counsel. Proceed.

112 MS. CLARK:

Sir, had a scientist with the equipment of the liquid chromatograph tandem mass spectrometer, if such a person had that equipment, could they, between the beginning of March when you provided your results to the Defense and now, have conducted tests on the socks and on the gate to determine the presence of EDTA-preserved blood?

113 MR. MARTZ:

Yes, they could.

114 MS. CLARK:

And in that space of time, sir, could they also have conducted tests involving the use of an internal standard like the one pointed out to you by counsel from Cambridge to quantify the amount of blood being tested in the evidence as well as the reference sample?

115 MR. MARTZ:

They could have quantitated the amount of EDTA. To quantitate the blood they would have had to use a different procedure.

116 MS. CLARK:

But they could have adopted a procedure to quantitate the blood?

117 MR. MARTZ:

Yes.

118 MS. CLARK:

And they could have then tested that blood?

119 MR. MARTZ:

Yes.

120 MS. CLARK:

And they could have then quantitated the EDTA present in the evidence and in the reference blood?

121 MR. MARTZ:

Yes, they could have.

122 MS. CLARK:

This is Defense 1274, sir.

123 MS. CLARK:

Can you tell us what was the point of this?

124 MR. MARTZ:

Well, when I made the five microliters blood sample I was able to cut it in pieces and determine my minimum detectable amount of bloodstain.

125 MS. CLARK:

And what were you attempting to show here?

126 MR. MARTZ:

Well, I needed a certain amount of blood in order to determine the minimum--the minimum detectable amount, so I placed a known amount of blood and took a portion of that and tested it.

127 MS. CLARK:

Okay. Were you trying to visualize what that amount of blood would look like?

128 MR. MARTZ:

No.

129 MS. CLARK:

That was just bloodstains showing that was the amount that you were testing?

130 MR. MARTZ:

Yes, that's correct.

131 MS. CLARK:

Not what it would look like?

132 MR. MARTZ:

No.

133 MS. CLARK:

All right. You were shown--I'm going to show you what is--

134 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
135 MS. CLARK:

You were shown People's 544-E--and your Honor, I have informally these. I'm going to ask leave of the Court to label them with handwriting or typing that is better than mine. Okay. These show the photographs of the evidence bloodstain on the gate?

136 MR. MARTZ:

Yes.

137 MS. CLARK:

And in this chart you indicated that the 160 was not shown in the full daughter spectrum?

138 MR. MARTZ:

That's correct.

139 MS. CLARK:

Although you had indicated you detected it you thought in the scan where you were only looking at the daughter 160 on the gate evidence, correct?

140 MR. MARTZ:

Yes, that's correct.

141 MS. CLARK:

What does this signify to you that when you ran the full daughter spectrum to try and achieve 293, 160 and 132 at the same time, you could not do so?

142 MR. MARTZ:

It indicated to me that I could not identify EDTA because I needed those ions to identify EDTA.

143 MS. CLARK:

And you hypothesized with Mr. Blasier that the 160 was below your detectable limit?

144 MR. MARTZ:

That's correct.

145 MS. CLARK:

Well, if it is below your detectable limit, sir, then can it be EDTA from preserved blood?

146 MR. MARTZ:

No, it cannot.

147 MS. CLARK:

Is that because the signal given--no matter how small the amount of blood, the signal given for EDTA blood is so strong that you should get the full daughter spectrum whenever you run it?

148 MR. MARTZ:

That's correct.

149 MS. CLARK:

And so you did not?

150 MR. MARTZ:

And I did not in this case.

151 MS. CLARK:

You were shown this chart, sir, by Mr. Blasier?

152 MR. MARTZ:

Yes, I was.

153 MS. CLARK:

Does that chart reflect any testing that you ever conducted?

154 MR. MARTZ:

No, it does not.

155 MS. CLARK:

Does that chart reflect any result that you ever obtained in any test?

156 MR. MARTZ:

No, it does not.

157 MS. CLARK:

Does that chart have anything to do with the work that you have done and actually obtained the results in in this case?

158 MR. MARTZ:

No, it does not.

159 MS. CLARK:

Does that chart reflect the results of the testing of any evidence in this case?

160 MR. MARTZ:

No, it does not.

161 MS. CLARK:

Or any of the reference samples in this case?

162 MR. MARTZ:

No, it does not.

163 MS. CLARK:

Is that an accurate depiction of your testimony as it relates to the comparison between the amount of EDTA found in preserved blood versus the amount of whatever substance that is in the evidence stains?

164 MR. MARTZ:

Could you repeat that, please?

KEY QUOTE
165 MS. CLARK:

No.

166 MR. MARTZ:

I didn't think you could.

KEY QUOTE
167 MS. CLARK:

I'm not even going to try and read it.

168 MS. CLARK:

Does this chart, sir, reflect your--accurately reflect your testimony concerning the discrepancy, the dramatic difference between the EDTA signal you got from the reference samples, that means blood from preserved EDTA tubes, and the evidence stains in this case?

169 MR. MARTZ:

This chart does not reflect any of the testing that I did whatsoever.

KEY QUOTE
170 MS. CLARK:

Does it accurately reflect any of your testimony, in your opinion, concerning the dramatic difference between the signals you got in the reference sample and the evidence stains?

171 MR. MARTZ:

No, it does not.

172 THE COURT:

All right. Miss Clark, you have been referring to--

173 MS. CLARK:

That was Defense 127--

174 MR. BLASIER:

1271-C.

175 MS. CLARK:

Thank you.

176 MS. CLARK:

Now, you recall being shown a square from the sock--there was a chart done by the Defense--

177 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
178 MS. CLARK:

Defense 1257-E.

179 MS. CLARK:

Sir, do you remember this diagram?

180 MR. MARTZ:

Yes, I do.

181 MS. CLARK:

It indicates that 207 was taken from the lower right-hand corner as you face this diagram?

182 MR. MARTZ:

Yes.

183 MS. CLARK:

Do you have any idea whether that is true or not?

184 MR. MARTZ:

No, I don't know where 207 came from.

185 MS. CLARK:

When you received 207 was it a cutting in a tube?

186 MR. MARTZ:

Yes, it was.

187 MS. CLARK:

And then you took a cutting from that?

188 MR. MARTZ:

Yes.

189 MS. CLARK:

Now, you indicated that you in fact did test 207 and 206 on the first day?

190 MR. MARTZ:

That's correct.

191 MS. CLARK:

Did you take a cutting from the small cutting you found in the tube marked 207?

192 MR. MARTZ:

Yes.

193 MS. CLARK:

And the cutting 206 is the one you made from the sock itself?

194 MR. MARTZ:

That's correct.

195 MS. CLARK:

You do not know then whether 207 actually came--came from the area right next to 206?

196 MR. MARTZ:

No. To my understanding it just came from somewhere in that blue area or blue/green area.

197 MS. CLARK:

Now, when you did the combined testing of 206 and 207, was that in the negative ion mode?

198 MR. MARTZ:

Yes, it was.

199 MS. CLARK:

And your result was?

200 MR. MARTZ:

No EDTA was identified in that particular stain and that stain did not come from preserved blood.

201 MS. CLARK:

Now, sir, you indicated--I'm going to show you the two charts that have been previously marked as People's 543 and 544-F respectively. These are labeled--this is the gate with EDTA blood applied. This is where you put known EDTA blood on the gate swatch.

202 MR. BLASIER:

Your Honor, object. Asked and answered.

203 THE COURT:

Overruled.

204 MS. CLARK:

If the blood recovered from the gate, the evidence blood in this case, were actually blood from the tube with preservative EDTA in it, is this the signal you would expect to get?

205 MR. MARTZ:

Yes, it is.

206 MS. CLARK:

And when you tested the actual blood recovered from the gate, the evidence blood, is that the signal you got?

207 MR. MARTZ:

No, I did not.

208 MS. CLARK:

And look at the chart now up.

209 MR. MARTZ:

That is the signal I got, yes.

210 MS. CLARK:

And that is the signal you got that is on People's 544-E?

211 MR. MARTZ:

Yes, that's correct.

212 MS. CLARK:

And if you had--and if the blood on the sock had in fact been blood from an EDTA preserved tube, would you have expected to get the signal shown in People's 543-F?

213 MR. MARTZ:

Yes, I would have.

214 MS. CLARK:

And is that the result that you got?

215 MR. MARTZ:

No, it is not.

216 MS. CLARK:

Showing you People's 543-E. This is the--your graph of the evidence blood tested for EDTA on the sock. This is the actual evidence. Is that the result that you got?

217 MR. MARTZ:

Yes, it is.

218 MS. CLARK:

And in each case, with respect to the blood recovered from the sock and the blood recovered from the gate, did your test results consistently show from May 19th through May 22nd or 23rd--

219 MR. MARTZ:

28th.

220 MS. CLARK:

--28th, that there was no EDTA preserved blood in the stain on the gate and the stain on the sock?

221 MR. MARTZ:

In all the tests that I performed no EDTA was identified in the stain from the gate or the stain from the sock. Those stains did not come from EDTA-preserved blood.

KEY QUOTE
222 MS. CLARK:

Do you have any doubt about that, sir?

223 MR. MARTZ:

I have no doubt whatsoever.

KEY QUOTE

Temperature

tense

Key Quotes (5)

Roger Martz
In all the tests that I performed no EDTA was identified in the stain from the gate or the stain from the sock. Those stains did not come from EDTA-preserved blood.
The definitive summary conclusion of Martz's entire testimony, delivered cleanly at the end of Clark's recross to counter any damage from cross.
Roger Martz
I have no doubt whatsoever.
Clark's closing line of questioning ends on an unequivocal statement of certainty — a deliberate rhetorical endpoint.
Roger Martz
This chart does not reflect any of the testing that I did whatsoever.
Martz repudiates Defense exhibit 1271-C entirely — the chart Blasier had used on cross to suggest Martz's comparison was misleading — as having no connection to his actual results.
Robert Blasier
Agent Martz told me right after lunch there is ten microliters in each one of these drops. I think he is becoming deceptive by denying that, and I want to state as an officer of the court that is what he said.
A rare moment where defense counsel accuses a witness of active deception at sidebar, threatening to call himself as an impeachment witness — reveals how high the stakes were on the quantification issue.
Roger Martz
Could you repeat that, please? / I didn't think you could.
Rare moment of levity and candor — Martz acknowledges Clark's question was incoherent, and Clark laughs it off rather than restating it.

Evidence (7)

Defense 1274
Photograph of five-microliter blood samples used to establish minimum detectable amount of bloodstain
discussed — Clark clarified this showed testing quantity, not a visual reconstruction
People's 544-E
Graph of evidence blood from the Bundy gate tested for EDTA
discussed — contrasted with what signal would appear if blood came from EDTA-preserved tube
People's 544-F
Graph of gate swatch with known EDTA-preserved blood applied (reference positive)
discussed — used to show what EDTA signal should look like if present
People's 543
Graph of EDTA-preserved blood reference for sock testing
discussed — positive control contrasted with actual sock evidence results
People's 543-E
Graph of actual evidence blood from the sock tested for EDTA
discussed — confirmed as the result Martz actually obtained, showing no EDTA
Defense 1271-C
Defense-prepared chart purporting to compare EDTA levels in preserved blood versus evidence stains
challenged — Martz confirmed it does not reflect any test he conducted, any result he obtained, or any evidence in this case
+ 1 more

Notable Exchanges (3)

Marcia ClarkRoger Martz
Clark walks Martz through a rapid sequence of five questions about Defense exhibit 1271-C, each time confirming it does not reflect any test conducted, any result obtained, or any evidence in the case — methodically nullifying the chart's impact from cross.
strategic
Marcia ClarkRobert BlasierLance A. ItoJohnnie Cochran
Sidebar erupts when Blasier argues Clark's questions about whether 'any scientist' could have done additional testing are improperly shifting the burden of proof to the defense. Ito agrees to limit phrasing to neutral 'any scientist' framing but calls it fair argument that the opportunity existed. Cochran pushes to strike prior questions; Ito declines.
heated
Robert BlasierLance A. ItoMarcia Clark
At sidebar, Blasier accuses Martz of deception — claiming Martz told him after lunch that each sample drop contained ten microliters, then denied it on the stand. Blasier raises the prospect of calling himself as an impeachment witness. Ito defers resolution until after the jurors are released for family visitation.
revealing

Light Moments (2)

Marcia Clark / Lance A. Ito
Clark announces 'We lost our operator, your Honor' when the court's display equipment fails. Ito replies 'Well, try it the old-fashioned way.' Clark responds: 'What is that? I forgot.'
Marcia Clark / Roger Martz
Clark asks an impossibly convoluted question; Martz asks her to repeat it. Clark says simply 'No.' Martz: 'I didn't think you could.' Clark: 'I'm not even going to try and read it.'

Credibility Attacks (2)

⚔ Roger Martz
Prior inconsistent statement (alleged)
Blasier claims at sidebar that Martz told him immediately after lunch that each sample drop contained ten microliters, then denied or contradicted that figure on the stand. Blasier characterizes this as Martz 'becoming deceptive' and raises the possibility of calling himself as a witness to impeach. Not resolved on the record during this session.
⚔ Defense expert (implied — Rieders / uncalled experts)
Failure to test / absence of counter-evidence
Clark elicits from Martz that any scientist with the proper LC-MS/MS equipment had ample time between March and trial to replicate his tests, use an internal standard for quantification, or conduct degradation experiments — and that to his knowledge no such tests were done by the defense.

Witness Demeanor

(Brief pause.) — during transition to detection limit questions when equipment failed
Martz's dry humor on the unreadable question — relaxed and cooperative throughout recross, in contrast to the adversarial tone of cross

Objections

3 objections (0 sustained, 2 overruled)
Proceeding 7032 • 223 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 JUL 26, 1995 📄 Recross-examination of Roger M
JUL 26, 1995 KRT DvH TD